Table 4.
Severity of COVID-19 infection in patients with CLL and other indolent NHLs.
| NIH clinical spectrum | All patients (n = 30) | CLL (n = 22) | WM and other NHLs (n = 8) |
|---|---|---|---|
| Asymptomatic infection | 3% (1/30) | — | 13% (1/8) |
| Mild/moderate illness | 70% (21/30) | 77% (17/22) | 50% (4/8) |
| Severe illness | 17% (5/30) | 14% (3/22) | 25% (2/8) |
| Critical illness | 10% (3/30) | 9% (2/22) | 13% (1/8) |
| COVID-19 deaths | 7% (2/30) | 9% (2/22) | — |